Nuevolution AB (publ) announces timing for the release and webcast of the first quarter 2019 interim results
Stockholm, 15 May 2019 – Nuevolution AB (publ) (NUE.ST) announces today that it will report its interim report for the first quarter 2019 on Wednesday, 22 May 2019 after 18:00 CET.
On Thursday, 23 May 2019 at 15:00 CET, the company’s executive management will host a conference call and webcast discussion of the results and provide an update on the pipeline programs and partnering activities. Access to the event can be obtained as follows:
LIVE access on Thursday 23 May at 15:00 CET
SE: +46 85 05 58 352
DK: +45 7815 0108
UK: +44 33 3300 9030
US: +1 833 5268 380
Webcast will be available at www.nuevolution.com in the Investors section and at www.financialhearings.com
Webcast replay will be available at www.nuevolution.com in the Investors section and at www.financialhearings.com
For more information, please contact:
Alex Haahr Gouliaev, CEO
Phone: +45 3913 0902
Johnny Stilou, CFO
Phone: +45 8877 5973
Information about Nuevolution AB (publ)
Nuevolution AB (publ) is a leading small molecule drug discovery biotech company founded in 2001, and headquartered in Copenhagen, Denmark. Nuevolution partners its discovery platform and develops its programs alone and in collaboration with pharmaceutical and biotechnology companies to seek future benefit for patients in need of novel medical treatment options. Nuevolution’s internal programs are focused on therapeutically important diseases targets within severe inflammatory diseases and cancer.
The information was sent for publication, through the agency of the contact persons set out above, on Wednesday 15 May 2019 at 18:00 CET.
Nuevolution AB (publ) is listed at Nasdaq in Stockholm, Sweden (ticker: NUE). More information about Nuevolution can be found on: www.nuevolution.com